Schedule 13D ownership disclosure
ALIGOS THERAPEUTICS INC
Security class unavailable · CUSIP: 01626L105
Event date: 2021-06-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-195127
- Form type
- SC 13D
- Filer
- Aligos Therapeutics, Inc.
- CIK
- CIK 1799448
- Filed
- Jun 21, 2021
- Reporting period
- Jun 17, 2021
- Description
- Schedule 13D beneficial ownership